Sphingolipids and Methionine Restriction Converge to Shape Cellular Aging

Aging is driven by gradual physiological decline and increasing vulnerability to chronic disease, yet its molecular underpinnings remain incompletely understood. This comprehensive review from Hariri and colleagues at Wayne State University tackles an emerging question: how does sphingolipid (SL) metabolism connect to methionine restriction (MetR), one of the most robust dietary interventions known to extend lifespan across multiple species?

SLs are a chemically diverse lipid class—including ceramides, sphingomyelin, glycosphingolipids, and sphingosine-1-phosphate—that serve dual roles as structural membrane components and bioactive signaling molecules. Their biosynthesis begins in the ER with serine palmitoyltransferase (SPT) and proceeds through the Golgi, lysosomes, and mitochondria, requiring tight coordination across organelles connected by membrane contact sites (MCS). Regulatory networks involving TORC1, TORC2, Orm proteins, and Ypk kinases balance SL synthesis with cellular demand, and nutrient status directly modulates this system.

A key insight of the review is that inhibiting SL synthesis—for example, with the SPT inhibitor myriocin—extends chronological lifespan in yeast. Emerging evidence suggests this effect mechanistically resembles MetR: both interventions appear to reduce intracellular methionine levels and downstream single-carbon metabolism activity. The authors hypothesize that SL remodeling may limit methionine consumption or redirect its metabolic flux, thereby mimicking the beneficial effects of dietary methionine reduction. Methionine feeds the S-adenosylmethionine (SAM) cycle, which drives epigenetic methylation, polyamine synthesis, and antioxidant production—processes directly relevant to aging.

The review also details how SL imbalances disrupt organelle function in aging. Age-related ceramide accumulation in mitochondria impairs oxidative phosphorylation and promotes ROS production. In lysosomes, excess SL buildup—as seen in lysosomal storage disorders and normal aging—impairs autophagy and proteostasis, causing secondary mitochondrial damage. SL-mediated phase separation at the yeast vacuole membrane regulates nutrient transport and lipophagy under starvation. Lipid transfer proteins at MCS, including CERT (mammals), Nvj2, and Mdm1 (yeast), coordinate inter-organelle SL trafficking; mutations in these proteins are linked to neurodegeneration and lifespan changes.

The authors acknowledge that the field is still early in understanding the causal direction between SL remodeling, methionine metabolism, and aging outcomes. Most mechanistic evidence comes from yeast models, with mammalian translation remaining incomplete. Nevertheless, the convergence of SL inhibition and MetR on shared longevity pathways—TORC1 inhibition, autophagy induction, reduced oxidative stress—makes this an exciting frontier for pharmacological intervention in age-related disease.